HomeLarge Type Edition
HOME ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Download to citation manager
PubMed
Right arrow PubMed Citation
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 58:M1111-M1118 (2003)
© 2003 The Gerontological Society of America


REVIEW ARTICLE

Gene Transfer to the Nervous System: Prospects for Novel Treatments Directed at Diseases of the Aging Nervous System

Marina Mata1,3, Joseph C. Glorioso2 and David J. Fink1,2,3

1 Department of Neurology
2 Department of Molecular Genetics and Biochemistry, University of Pittsburgh, Pennsylvania.
3 Geriatric Research, Education and Clinical Center, Pittsburgh VA Healthcare System, Pennsylvania.

In the past 3 decades, gene therapy has moved from a theoretical construct to an active field of basic research, animal studies, and clinical trials. In this article, we describe the conceptual basis underlying the use of gene therapy for diseases of the aging nervous system, the principal techniques used for gene delivery, and review preclinical animal studies in 4 different classes of neurologic dysfunction: 1) focal neuronal degeneration in the central nervous system; 2) global neuronal dysfunction in the central nervous system; 3) degenerative disease affecting components of the peripheral nervous system; and 4) intractable focal pain. The full potential of this approach will not be established until the human trials are completed.







HOME ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by The Gerontological Society of America.